<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Baxter International - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"68e4ed18-0e83-460c-bdbe-09381c063c1e","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Baxter_International","wgTitle":"Baxter International","wgCurRevisionId":945745743,"wgRevisionId":945745743,"wgArticleId":2432238,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Baxter_International","wgRelevantArticleId":2432238,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Baxter_International_Inc.",
"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Baxter_International","wgWikibaseItemId":"Q761965","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,
"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":!1,"simplifiedTalk":!0},"wgMinervaDownloadNamespaces":[0]};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["mediawiki.action.view.redirect","site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init",
"ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.28"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Baxter_International&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Baxter_International&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Baxter_International"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Baxter_International rootpage-Baxter_International stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Baxter+International" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Baxter+International" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Baxter International</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Baxter_International" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Baxter+International" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"><span class="mw-redirectedfrom">&#160;&#160;(Redirected from <a href="/w/index.php?title=Baxter_International_Inc.&amp;redirect=no" class="mw-redirect" title="Baxter International Inc.">Baxter International Inc.</a>)</span></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0"><p class="mw-empty-elt">
</p>
<p><b>Baxter International Inc.</b> is a <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a><sup id="cite_ref-auto_2-1" class="reference"><a href="#cite_note-auto-2">[2]</a></sup> American health care company with headquarters in <a href="/wiki/Deerfield,_Illinois" title="Deerfield, Illinois">Deerfield, Illinois</a>.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">[3]</a></sup> The company primarily focuses on products to treat <a href="/wiki/Hemophilia" class="mw-redirect" title="Hemophilia">hemophilia</a>, <a href="/wiki/Kidney_disease" title="Kidney disease">kidney disease</a>, <a href="/wiki/Immune_disorder" title="Immune disorder">immune disorders</a> and other <a href="/wiki/Chronic_condition" title="Chronic condition">chronic</a> and <a href="/wiki/Acute_(medicine)" title="Acute (medicine)">acute</a> medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces <a href="/wiki/Recombinant_proteins" class="mw-redirect" title="Recombinant proteins">recombinant</a> and <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a> proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for <a href="/wiki/Regenerative_medicine" title="Regenerative medicine">regenerative medicine</a>, and <a href="/wiki/Vaccine" title="Vaccine">vaccines</a>. Baxter's Medical Products business produces <a href="/wiki/Intravenous" class="mw-redirect" title="Intravenous">intravenous</a> products and other products used in the delivery of fluids and drugs to patients; <a href="/wiki/Inhalational_anaesthetic" class="mw-redirect" title="Inhalational anaesthetic">inhalational anaesthetics</a>; contract manufacturing services; and products to treat <a href="/wiki/End-stage_kidney_disease" class="mw-redirect" title="End-stage kidney disease">end-stage kidney disease</a>, or irreversible <a href="/wiki/Kidney_failure" title="Kidney failure">kidney failure</a>, including products for <a href="/wiki/Peritoneal_dialysis" title="Peritoneal dialysis">peritoneal dialysis</a> and <a href="/wiki/Hemodialysis" title="Hemodialysis">hemodialysis</a>.<sup id="cite_ref-2013_Form_10-K_4-0" class="reference"><a href="#cite_note-2013_Form_10-K-4">[4]</a></sup></p><table class="infobox vcard" style="width:22em"><caption class="fn org">Baxter International Inc.</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Baxter.svg" class="image"><img alt="Baxter.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d4/Baxter.svg/220px-Baxter.svg.png" decoding="async" width="220" height="37" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d4/Baxter.svg/330px-Baxter.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d4/Baxter.svg/440px-Baxter.svg.png 2x" data-file-width="749" data-file-height="127"></a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><div class="plainlist"><ul><li><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>: <a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:BAX">BAX</a></li><li><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500</a> component</li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US0718131099">US0718131099 </a><a href="https://www.wikidata.org/wiki/Q761965?uselang=en#P946" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Medical_equipment" class="mw-redirect" title="Medical equipment">Medical equipment</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1931<span class="noprint">; 89 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">1931</span>)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;"><a href="/wiki/Deerfield,_Illinois" title="Deerfield, Illinois">Deerfield, Illinois</a>, U.S.</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;"><a href="/wiki/Jos%C3%A9_E._Almeida" title="José E. Almeida">José E. Almeida</a>, (<a href="/wiki/Chairman" class="mw-redirect" title="Chairman">chairman</a> &amp; <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a>)<br>
Jay Saccaro, (<a href="/wiki/Chief_financial_officer" title="Chief financial officer">CFO</a>)</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Products</th><td style="line-height: 1.35em;">Medical supplies to treat <a href="/wiki/Hemophilia" class="mw-redirect" title="Hemophilia">hemophilia</a> and <a href="/wiki/Kidney_disease" title="Kidney disease">kidney disease</a> and provide <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous therapy</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300">US$10.561B (<i>FY 2017</i>)<sup id="cite_ref-2017_Form_10-K_1-0" class="reference"><a href="#cite_note-2017_Form_10-K-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300">US$717M (<i>FY 2017</i>)<sup id="cite_ref-2017_Form_10-K_1-1" class="reference"><a href="#cite_note-2017_Form_10-K-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300">US$17,111B (<i>FY 2017</i>)<sup id="cite_ref-2017_Form_10-K_1-2" class="reference"><a href="#cite_note-2017_Form_10-K-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300">US$9,116B (<i>FY 2017</i>)<sup id="cite_ref-2017_Form_10-K_1-3" class="reference"><a href="#cite_note-2017_Form_10-K-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;">48,000 <sup id="cite_ref-auto_2-0" class="reference"><a href="#cite_note-auto-2">[2]</a></sup> (2017)</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="http://baxter.com">baxter<wbr></wbr>.com</a></span></td></tr></tbody></table>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Former_employees"><span class="tocnumber">2</span> <span class="toctext">Former employees</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Environmental_activities"><span class="tocnumber">3</span> <span class="toctext">Environmental activities</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Structure"><span class="tocnumber">4</span> <span class="toctext">Structure</span></a>
<ul><li class="toclevel-2 tocsection-5"><a href="#Corporate_governance"><span class="tocnumber">4.1</span> <span class="toctext">Corporate governance</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-6"><a href="#H1N1_vaccine"><span class="tocnumber">5</span> <span class="toctext">H1N1 vaccine</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Philanthropy"><span class="tocnumber">6</span> <span class="toctext">Philanthropy</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Controversies"><span class="tocnumber">7</span> <span class="toctext">Controversies</span></a>
<ul><li class="toclevel-2 tocsection-9"><a href="#1975_Hemofil_hepatitis_B_outbreak"><span class="tocnumber">7.1</span> <span class="toctext">1975 Hemofil hepatitis B outbreak</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#1983_prison_plasma_collection"><span class="tocnumber">7.2</span> <span class="toctext">1983 prison plasma collection</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#1996_Japanese_haemophiliac_HIV_lawsuit"><span class="tocnumber">7.3</span> <span class="toctext">1996 Japanese haemophiliac HIV lawsuit</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#2001_Althane_disaster"><span class="tocnumber">7.4</span> <span class="toctext">2001 Althane disaster</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#2008_Chinese_heparin_adulteration"><span class="tocnumber">7.5</span> <span class="toctext">2008 Chinese heparin adulteration</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#2009_Avian_flu_contamination"><span class="tocnumber">7.6</span> <span class="toctext">2009 Avian flu contamination</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#2009_drug_cost_inflation"><span class="tocnumber">7.7</span> <span class="toctext">2009 drug cost inflation</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#2010_hepatitis_C_infections"><span class="tocnumber">7.8</span> <span class="toctext">2010 hepatitis C infections</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#2010_infusion_pump_recall"><span class="tocnumber">7.9</span> <span class="toctext">2010 infusion pump recall</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#2008%E2%80%932010_tax_avoidance"><span class="tocnumber">7.10</span> <span class="toctext">2008–2010 tax avoidance</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-19"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-20"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="History">History</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=1" title="Edit section: History" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<p>Baxter International was founded in 1931 by Donald Baxter, a <a href="/wiki/Los_Angeles" title="Los Angeles">Los Angeles</a>-based <a href="/wiki/Physician" title="Physician">medical doctor</a>, as a manufacturer and distributor of <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous therapy</a> solutions.<sup id="cite_ref-history_5-0" class="reference"><a href="#cite_note-history-5">[5]</a></sup> Seeing a need for products closer to the Midwest, the company opened a manufacturing plant in <a href="/wiki/Glenview,_Illinois" title="Glenview, Illinois">Glenview, Illinois</a>, in 1933.<sup id="cite_ref-history_5-1" class="reference"><a href="#cite_note-history-5">[5]</a></sup> Baxter's interest was bought out in 1935 by Ralph Falk, who established a <a href="/wiki/Research_and_development" title="Research and development">research and development</a> function.  In 1939 the company developed a vacuum-type collection container, extending the <a href="/wiki/Shelf_life" title="Shelf life">shelf life</a> of blood from hours to weeks.  In 1954, the company expanded operations outside of the United States by opening an office in <a href="/wiki/Belgium" title="Belgium">Belgium</a>. In 1956 Baxter International introduced the first functioning <a href="/wiki/Artificial_kidney" title="Artificial kidney">artificial kidney</a>, and in 1971 became a member of the <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a>.
</p><p>In 1971, Baxter built a major manufacturing plant in <a href="/wiki/Ashdod,_Israel" class="mw-redirect" title="Ashdod, Israel">Ashdod, Israel</a>, and as a result, the company was placed on the <a href="/wiki/Arab_League_boycott_of_Israel" title="Arab League boycott of Israel">Arab League boycott list</a> in the early 1980s.<sup id="cite_ref-boycott_6-0" class="reference"><a href="#cite_note-boycott-6">[6]</a></sup></p><p>Throughout the 1980s and 1990s the company expanded to deliver a wider variety of products and services (including vaccines, a greater variety of blood products) through acquisitions of various companies.  Sales and production facilities also expanded throughout the world.<sup id="cite_ref-history_5-2" class="reference"><a href="#cite_note-history-5">[5]</a></sup></p><p>In 1982, Baxter acquired Medcom, Inc., a <a href="/wiki/New_York_(state)" title="New York (state)">New York</a>-based firm founded by <a href="/wiki/Richard_Fuisz" title="Richard Fuisz">Richard Fuisz</a> and his brother, that had large markets in the United States and <a href="/wiki/Saudi_Arabia" title="Saudi Arabia">Saudi Arabia</a>.<sup id="cite_ref-tribune90_7-0" class="reference"><a href="#cite_note-tribune90-7">[7]</a></sup><sup id="cite_ref-edgar_8-0" class="reference"><a href="#cite_note-edgar-8">[8]</a></sup><sup id="cite_ref-mcall_9-0" class="reference"><a href="#cite_note-mcall-9">[9]</a></sup> Baxter chief executive Vernon Loucks fired Fuisz who then brought anti-boycott charges against Baxter to the <a href="/wiki/United_States_Department_of_Commerce" title="United States Department of Commerce">U.S. Commerce Department</a> Office of Anti-Boycott Compliance (OAC). Fuisz alleged that Baxter had sold their profitable Ashdod facility to <a href="/wiki/Teva_Pharmaceutical_Industries" class="mw-redirect" title="Teva Pharmaceutical Industries">Teva Pharmaceutical Industries</a> in 1988<sup id="cite_ref-bloomberg_1991_10-0" class="reference"><a href="#cite_note-bloomberg_1991-10">[10]</a></sup> while simultaneously negotiating the construction of a similar plant in Syria in partnership with the Syrian military in order to be removed from the Arab League blacklist in 1989.<sup id="cite_ref-boycott_6-1" class="reference"><a href="#cite_note-boycott-6">[6]</a></sup><sup id="cite_ref-washreport_11-0" class="reference"><a href="#cite_note-washreport-11">[11]</a></sup><sup id="cite_ref-tribune93_12-0" class="reference"><a href="#cite_note-tribune93-12">[12]</a></sup> In 1993 Baxter pleaded guilty to a <a href="/wiki/Felony" title="Felony">felony</a> in relation to an anti-<a href="/wiki/Boycott" title="Boycott">boycott</a> law in the United States.<sup id="cite_ref-bloomberg_1991_10-1" class="reference"><a href="#cite_note-bloomberg_1991-10">[10]</a></sup><sup id="cite_ref-Mintzberg_13-0" class="reference"><a href="#cite_note-Mintzberg-13">[13]</a></sup></p><p>In July 15, 1985, American Hospital Supply Corporation CEO Karl D. Bays and Baxter's then-CEO Vernon R. Loucks Jr. signed an agreement that merged two of the United States' "largest producers of medical supplies".<sup id="cite_ref-nytimes_1985_14-0" class="reference"><a href="#cite_note-nytimes_1985-14">[14]</a></sup> This was a "one-Baxter approach" in which the company provided "70% to 80% of what a hospital needed."<sup id="cite_ref-modernhealthcare_2006_15-0" class="reference"><a href="#cite_note-modernhealthcare_2006-15">[15]</a></sup></p><p>In 1991, Baxter's home infusion subsidiary, <a href="/wiki/CVS_Health" title="CVS Health">Caremark</a>, "was accused by the government of paying doctors to steer patients to its intravenous drug service"<sup id="cite_ref-chicagotribune_1995_16-0" class="reference"><a href="#cite_note-chicagotribune_1995-16">[16]</a></sup> In 1992 Caremark spun off from Baxter International.<sup id="cite_ref-chicagotribune_1995_16-1" class="reference"><a href="#cite_note-chicagotribune_1995-16">[16]</a></sup> Caremark was fined $160 million for the "four-year-long federal mail-fraud and kickback" scheme in which the "home-infusion business unit made weekly payments to scores of doctors that averaged about $75 per patient for referring those patients to its services. Some doctors earned as much as $80,000 a year from the kickbacks, according to government documents."<sup id="cite_ref-chicagotribune_1995_16-2" class="reference"><a href="#cite_note-chicagotribune_1995-16">[16]</a></sup></p><p>In 1996, the company entered into a four-way, $640 million settlement with <a href="/wiki/Haemophilia" title="Haemophilia">haemophiliacs</a> 1999 in relation to <a href="/wiki/Coagulation" title="Coagulation">blood clotting</a> concentrates that were infected with HIV.<sup id="cite_ref-Feldman_1999_17-0" class="reference"><a href="#cite_note-Feldman_1999-17">[17]</a></sup>  Under pressure from shareholders due to poor performance and an unsuccessful merger, Loucks was forced to resign.<sup id="cite_ref-Mintzberg_13-1" class="reference"><a href="#cite_note-Mintzberg-13">[13]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>115</span></sup></p><p>Baxter acquired medical device firm Baxa on November 10, 2011.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">[18]</a></sup> In 2011, <a href="/wiki/Hikma_Pharmaceuticals" title="Hikma Pharmaceuticals">Hikma</a> Pharmaceuticals PLC completed the acquisition of Baxter Healthcare Corporation's US generic injectables business (Multi-Source Injectables or MSI).<sup id="cite_ref-History_19-0" class="reference"><a href="#cite_note-History-19">[19]</a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20">[20]</a></sup></p><p>In July 2013, EU antitrust regulators approved Baxter's bid for <a href="/wiki/Sweden" title="Sweden">Sweden</a>'s <a href="/wiki/Gambro" title="Gambro">Gambro</a>.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">[21]</a></sup></p><p>In March 2014, Baxter announced plans to create two separate, independent global healthcare companies—one focused on developing and marketing bio-pharmaceuticals and the other on medical products. The medical products company retained the name Baxter International Inc. and the bio-pharmaceuticals company is named <a href="/wiki/Baxalta" title="Baxalta">Baxalta</a> and <a href="/wiki/Corporate_spin-off" title="Corporate spin-off">spun-off</a> as a new public company that showed on trading boards as of July 1, 2015.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">[22]</a></sup></p><p>In July 2014, Baxter announced that it was exiting the vaccines business—divesting its commercial vaccine portfolio to Pfizer (with the sale expected to close by the end of the year) and exploring options for its vaccines R&amp;D program, including influenza.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">[23]</a></sup> In October 2015, José E. Almeida was named chairman and chief executive officer.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">[24]</a></sup> In January 2016 Shire PLC agreed to acquire Baxalta for $32 billion.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">[25]</a></sup></p><p>In December 2016, Baxter announced it would acquire Claris Lifesciences injectables subsidiary, Claris Injectables, for $625 million.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">[26]</a></sup></p><p>In December 2019, the company announced it would acquire <a href="/w/index.php?title=Seprafilm&amp;action=edit&amp;redlink=1" class="new" title="Seprafilm (page does not exist)">Seprafilm</a> from <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a> for $350 million.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">[27]</a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28">[28]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Former_employees">Former employees</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=2" title="Edit section: Former employees" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<p>During the tenure of Vernon Loucks, who was Baxter's CEO from 1980 to 1998 and chairman from 1987 to 1999, company sales "more than quadrupled to $5.7 billion while its workforce rose from 30,000 to 42,000." During that time, Loucks hired and groomed staff who went on to become CEOs elsewhere. Baxter alumni groomed by Loucks included Terry Mulligan of MedAssets, Lance Piccolo at Caremark, Mike Mussallem of Edwards Lifesciences Corp and CEOs of Boston Scientific Corp. and Cardinal Health.<sup id="cite_ref-modernhealthcare_2006_15-1" class="reference"><a href="#cite_note-modernhealthcare_2006-15">[15]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Environmental_activities">Environmental activities</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=3" title="Edit section: Environmental activities" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<p>In 1997, a report produced by the company indicated that changes made to reduce environmental impacts generated savings that exceeded their cost, producing a net profit.  Reporting was company-wide, with a variety of aggregation and reporting, including on the company's internet and intranet sites.<sup id="cite_ref-Klinkers1999_29-0" class="reference"><a href="#cite_note-Klinkers1999-29">[29]</a></sup> The company was an early joiner in the "green and greedy" movement, which aims to lessen the environmental impacts of manufacturing its products while saving the company money.<sup id="cite_ref-greengreedy_30-0" class="reference"><a href="#cite_note-greengreedy-30">[30]</a></sup>  In 2009 the company announced it had reached a variety of its environmentally friendly goals, and that it would continue to try to reduce waste, emissions, energy use and environmental incidents over the coming years.<sup id="cite_ref-emissions_31-0" class="reference"><a href="#cite_note-emissions-31">[31]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Structure">Structure</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=4" title="Edit section: Structure" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<table class="wikitable sortable"><caption>Baxter International by businessline<sup id="cite_ref-corpoverview_32-0" class="reference"><a href="#cite_note-corpoverview-32">[32]</a></sup><sup id="cite_ref-Davis2003_33-0" class="reference"><a href="#cite_note-Davis2003-33">[33]</a></sup></caption>
<tbody><tr><th>Name</th>
<th>Focus</th>
<th>2013 sales (in billions)</th>
<th>Percentage of total sales
</th></tr><tr><td>BioScience</td>
<td><a href="/wiki/Hemophilia" class="mw-redirect" title="Hemophilia">Hemophilia</a> therapy; <a href="/wiki/Monoclonal_antibody_therapy" title="Monoclonal antibody therapy">antibody therapy</a>; critical care therapy; pulmonology therapy; biosurgery products; <a href="/wiki/Vaccines" class="mw-redirect" title="Vaccines">vaccines</a></td>
<td>$6.4</td>
<td>43%
</td></tr><tr><td>Medical Products</td>
<td>IV solutions, premixed drugs, <a href="/wiki/Infusion_pump" title="Infusion pump">infusion pumps</a> and administration sets; <a href="/wiki/Parenteral_nutrition" title="Parenteral nutrition">parenteral nutrition</a> products; <a href="/wiki/Anesthesia" title="Anesthesia">anesthesia</a>; drug formulation and pharma partnering; <a href="/wiki/Peritoneal_dialysis" title="Peritoneal dialysis">peritoneal dialysis</a> products; <a href="/wiki/Hemodialysis" title="Hemodialysis">hemodialysis</a> products; <a href="/wiki/Continuous_renal_replacement_therapy" class="mw-redirect" title="Continuous renal replacement therapy">continuous renal replacement therapy</a></td>
<td>$10.3</td>
<td>57%
</td></tr></tbody></table><p>The company had 2014 sales of $16.7 billion, across two businesses: BioScience (2013 sales - $6.6 billion) and Medical Products ($8.7 billion).<sup id="cite_ref-2013_Form_10-K_4-1" class="reference"><a href="#cite_note-2013_Form_10-K-4">[4]</a></sup> Sales in 2013 were 42% in the United States, 30% in Europe, 16% in Asia Pacific, 12% in Latin America and Canada. In 2011, Baxter had approximately 61,500 employees. The breakdown of regional employees in 2013 was 36% in the United States; 34% in Europe; 16% in Asia Pacific; 14% in Latin America and Canada. In 2013, Baxter International spent more than $1.2 billion on research and development.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">[34]</a></sup> As of December 31, 2016, the company had approximately 48,000 employees.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">[35]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Corporate_governance">Corporate governance</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=5" title="Edit section: Corporate governance" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 1953 William Graham became the company's <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a>.  Vernon Loucks became <a href="/wiki/President_(corporate_title)" title="President (corporate title)">president</a> and CEO in 1980.  Loucks was forced to resign by <a href="/wiki/Shareholder" title="Shareholder">shareholders</a>.<sup id="cite_ref-Mintzberg_13-2" class="reference"><a href="#cite_note-Mintzberg-13">[13]</a></sup> When shareholders forced Loucks to resign,<sup id="cite_ref-wsj_1999_36-0" class="reference"><a href="#cite_note-wsj_1999-36">[36]</a></sup></p>
<style data-mw-deduplicate="TemplateStyles:r886047036">.mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0}</style><blockquote class="templatequote"><p>"In January, as Baxter International Inc.'s Vernon Loucks relinquished his CEO duties after 18 years, directors handed him a special stock-option grant of 950,000 shares "for the specific purposes of motivating" him "to implement a smooth transition of his responsibilities." If Mr. Loucks sells all the 400,000 shares he can exercise at year end and Baxter's stock price remains at its current level, he will make more than $4 million."</p><div class="templatequotecite">— <cite><i>The Wall Street Journal</i>, April 29, 1999</cite></div></blockquote>
<p>Loucks was succeeded by <a href="/wiki/Harry_Kraemer" title="Harry Kraemer">Harry Kraemer</a>, who was succeeded by Robert Parkinson, who took the CEO position in 2004.<sup id="cite_ref-history_5-3" class="reference"><a href="#cite_note-history-5">[5]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="H1N1_vaccine">H1N1 vaccine</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=6" title="Edit section: H1N1 vaccine" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<p>In June 2009, Baxter International announced it expected to have the first commercial <a href="/wiki/Vaccine" title="Vaccine">vaccine</a> for the <a href="/wiki/Influenza_A_virus_subtype_H1N1" title="Influenza A virus subtype H1N1">H1N1 ("swine flu") influenza</a> as early as July of the same year. The company has been one of several working with the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> and United States <a href="/wiki/Centers_for_Disease_Control_and_Prevention" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> on the vaccine, and uses a <a href="/wiki/Cell_(biology)" title="Cell (biology)">cell</a>-based rather than <a href="/wiki/Egg_(food)" class="mw-redirect" title="Egg (food)">egg</a>-based technology that allows a shorter production time.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">[37]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(6)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Philanthropy">Philanthropy</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=7" title="Edit section: Philanthropy" data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-6 collapsible-block" id="mf-section-6">
<p>In 2008, Baxter launched Science@Work: Expanding Minds with Real-World Science, which supports teacher training and student development in healthcare and biotechnology in Chicago Public Schools.<sup id="cite_ref-Baxter_2014_ed_38-0" class="reference"><a href="#cite_note-Baxter_2014_ed-38">[38]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>17</span></sup></p><p>In 2013, the company was included in The Civic 50, a list of the most community-minded companies in America from The National Conference on Citizenship and Points of Light, published by Bloomberg.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">[39]</a></sup></p><p>In 2014, roughly 6,300 Baxter employees volunteered in their communities through The Baxter International Foundation's Dollars for Doers program, addressing local concerns such as healthcare, the environment and education.<sup id="cite_ref-Baxter_2014_em_40-0" class="reference"><a href="#cite_note-Baxter_2014_em-40">[40]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>104</span></sup> In 2014, Baxter and The Baxter International Foundation gave over $50 million.<sup id="cite_ref-Baxter_2014_cm_41-0" class="reference"><a href="#cite_note-Baxter_2014_cm-41">[41]</a></sup></p><p>Baxter was included for the 13th year in <i>Corporate Responsibility</i> magazine's 100 Best Corporate Citizens list in 2014 for its social responsibility performance.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">[42]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(7)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Controversies">Controversies</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=8" title="Edit section: Controversies" data-section="8" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-7 collapsible-block" id="mf-section-7">
<h3 class="in-block"><span class="mw-headline" id="1975_Hemofil_hepatitis_B_outbreak">1975 Hemofil hepatitis B outbreak</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=9" title="Edit section: 1975 Hemofil hepatitis B outbreak" data-section="9" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In August 1975, Baxter / Travenol withdrew a clotting factor product Hemofil after the product was associated with an outbreak of hepatitis B.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43">[43]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="1983_prison_plasma_collection">1983 prison plasma collection</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=10" title="Edit section: 1983 prison plasma collection" data-section="10" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Baxter, unknown to the FDA, continued to use prison plasma in factor concentrate production until October 1983, despite having entered into an agreement with the FDA (11 months earlier) that they would no longer use US prison plasma, which posed a high risk of virus transmission.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">[44]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="1996_Japanese_haemophiliac_HIV_lawsuit">1996 Japanese haemophiliac <a href="/wiki/HIV" title="HIV">HIV</a> lawsuit</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=11" title="Edit section: 1996 Japanese haemophiliac HIV lawsuit" data-section="11" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>It was announced in quarter 1 of 1996 that Baxter had agreed to settle a lawsuit involving 200 Japanese haemophilia patients who had become infected with HIV as a result of using <a href="/wiki/Contaminated_haemophilia_blood_products" title="Contaminated haemophilia blood products">contaminated haemophilia products</a> which were unheated. The Japanese courts ordered for each victim to receive $411,460 by March 29 that year.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">[45]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2001_Althane_disaster">2001 Althane disaster</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=12" title="Edit section: 2001 Althane disaster" data-section="12" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Baxter_Althane_disaster" title="Baxter Althane disaster">Baxter Althane disaster</a></div>
<p>The Baxter Althane disaster in autumn 2001 was a series of 56 sudden deaths of <a href="/wiki/Kidney_failure" title="Kidney failure">kidney failure</a> patients in Spain, Croatia, Italy, Germany, Taiwan, Colombia and the USA (mainly Nebraska and Texas). All had received hospital treatment with Althane <a href="/wiki/Hemodialysis" title="Hemodialysis">hemodialysis</a> equipment, a product range manufactured by Baxter International, USA.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">[46]</a></sup><sup id="cite_ref-47" class="reference"><a href="#cite_note-47">[47]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2008_Chinese_heparin_adulteration">2008 Chinese heparin adulteration</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=13" title="Edit section: 2008 Chinese heparin adulteration" data-section="13" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/2008_Chinese_heparin_adulteration" title="2008 Chinese heparin adulteration">2008 Chinese heparin adulteration</a></div>
<p>In 2008, the quality of blood thinning products produced by Baxter was brought into question when they were linked to 81 deaths and 785 severe allergic reactions in the United States according to the FDA.<sup id="cite_ref-John_Wiley_&amp;_Sons_48-0" class="reference"><a href="#cite_note-John_Wiley_&amp;_Sons-48">[48]</a></sup> Upon inspection, one of the raw ingredients used by Baxter was found to be contaminated – between 5 and 20 percent – with a substance that was similar, but not identical, to the ingredient itself. The company initiated a voluntary recall, temporarily suspended the manufacture of <a href="/wiki/Heparin" title="Heparin">heparin</a>, and launched an investigation.
</p><p>The investigation into the contamination has focused on raw heparin produced by one of Baxter's subcontractors Changzhou Scientific Protein Laboratories, a China-based branch of <a href="/wiki/Scientific_Protein_Laboratories" title="Scientific Protein Laboratories">Scientific Protein Laboratories</a>, based in <a href="/wiki/Waunakee,_Wisconsin" title="Waunakee, Wisconsin">Waunakee, Wisconsin</a>. Changzhou SPL's facilities were never subjected to inspection by US FDA officials. In addition, Changzhou SPL's products were also never certified as safe for use in pharmaceutical products by Chinese FDA officials, due to Changzhou SPL's registration as a chemical company rather than a pharmaceutical manufacturer.<sup id="cite_ref-wp1_49-0" class="reference"><a href="#cite_note-wp1-49">[49]</a></sup><sup id="cite_ref-reuters1_50-0" class="reference"><a href="#cite_note-reuters1-50">[50]</a></sup><sup id="cite_ref-wsj1_51-0" class="reference"><a href="#cite_note-wsj1-51">[51]</a></sup></p><p>Upon investigation of these adverse events by the FDA, academic institutions, and the involved pharmaceutical companies, the contaminant was identified as an "over-sulfated" derivative of <a href="/wiki/Chondroitin_sulfate" title="Chondroitin sulfate">chondroitin sulfate</a>, a closely related substance obtained from mammal or fish cartilage and often used as a treatment for <a href="/wiki/Arthritis" title="Arthritis">arthritis</a>.<sup id="cite_ref-time1_52-0" class="reference"><a href="#cite_note-time1-52">[52]</a></sup><sup id="cite_ref-53" class="reference"><a href="#cite_note-53">[53]</a></sup> Since over-sulfated chondroitin is not a naturally occurring molecule, it costs a fraction of true heparin precursor chemical, and mimics the in-vitro properties of heparin, the counterfeit was almost certainly intentional as opposed to an accidental lapse in manufacturing.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">[54]</a></sup>  The raw heparin batches were found to have been cut from 2–60% with the counterfeit substance, and motivation for the adulteration was attributed to a combination of cost effectiveness and a shortage of suitable pigs in Mainland China. In mid-January 2008 Baxter voluntarily recalled some lots of multi-dose vials of Heparin in February in consultation with the FDA Baxter recalled the rest of their Heparin products.<sup id="cite_ref-John_Wiley_&amp;_Sons_48-1" class="reference"><a href="#cite_note-John_Wiley_&amp;_Sons-48">[48]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2009_Avian_flu_contamination">2009 Avian flu contamination</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=14" title="Edit section: 2009 Avian flu contamination" data-section="14" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In early 2009, samples of viral material supplied by Baxter International to a series of European laboratories were found to be contaminated with live Avian flu virus (<a href="/wiki/Influenza_A_virus_subtype_H5N1" title="Influenza A virus subtype H5N1">Influenza A virus subtype H5N1</a>).<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">[55]</a></sup> Samples of the less harmful seasonal flu virus (subtype H3N2) were found to be mixed with the deadly H5N1 strain after a vaccine made from the material killed test animals in a lab in the <a href="/wiki/Czech_Republic" title="Czech Republic">Czech Republic</a>. Though the serious consequences were avoided by the lab in the Czech Republic,<sup id="cite_ref-CTV_2009_56-0" class="reference"><a href="#cite_note-CTV_2009-56">[56]</a></sup> Baxter then claimed the failed controls over the distribution of the virus were 'stringent' and there was 'little chance' of the lethal virus harming humans.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57">[57]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2009_drug_cost_inflation">2009 drug cost inflation</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=15" title="Edit section: 2009 drug cost inflation" data-section="15" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>On July 2, 2009, <a href="/wiki/Kentucky" title="Kentucky">Kentucky</a> Attorney General <a href="/wiki/Jack_Conway_(politician)" title="Jack Conway (politician)">Jack Conway</a> announced a settlement between the state and Baxter Healthcare Corporation, a subsidiary of Baxter International, worth $2 million. The company had been inflating the cost of the <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous drugs</a> sold to Kentucky Medicaid, at times as much as 1300%.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58">[58]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2010_hepatitis_C_infections">2010 hepatitis C infections</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=16" title="Edit section: 2010 hepatitis C infections" data-section="16" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2010, a jury in <a href="/wiki/Las_Vegas,_Nevada" class="mw-redirect" title="Las Vegas, Nevada">Las Vegas, Nevada</a>, ordered Baxter and Teva Pharmaceuticals to pay $144 million to patients who had been infected with <a href="/wiki/Hepatitis_C" title="Hepatitis C">hepatitis C</a> after doctors wrongly reused dirty medical supplies to administer <a href="/wiki/Propofol" title="Propofol">propofol</a> to patients, although the label for propofol clearly states that it is for single-patient use only and that aseptic procedures should be used at all times.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">[59]</a></sup> Per a 2009 indemnity agreement between Teva (the manufacturer) and Baxter (acting as a distributor on behalf of Teva), the litigation and related settlements were defended and paid by Teva.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">[60]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2010_infusion_pump_recall">2010 infusion pump recall</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=17" title="Edit section: 2010 infusion pump recall" data-section="17" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2010, Baxter was ordered by the FDA to recall all of their Colleague infusion pumps from the market due to 87 recalls and deaths associated with the pump.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61">[61]</a></sup></p>
<h3 class="in-block"><span id="2008.E2.80.932010_tax_avoidance"></span><span class="mw-headline" id="2008–2010_tax_avoidance">2008–2010 tax avoidance</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=18" title="Edit section: 2008–2010 tax avoidance" data-section="18" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In December 2011, the non-partisan organization <a href="/wiki/Public_Campaign#Reports" class="mw-redirect" title="Public Campaign">Public Campaign</a> criticized Baxter for spending $10.45 million on <a href="/wiki/Lobbying" title="Lobbying">lobbying</a> and not paying any taxes during 2008–2010, instead getting $66 million in tax rebates, despite making a profit of $926 million.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62">[62]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(8)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="References">References</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=19" title="Edit section: References" data-section="19" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-8 collapsible-block" id="mf-section-8">
<div class="reflist" style="list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="references"><li id="cite_note-2017_Form_10-K-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-2017_Form_10-K_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-2017_Form_10-K_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-2017_Form_10-K_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-2017_Form_10-K_1-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDAxNDU0fENoaWxkSUQ9LTF8VHlwZT0z&amp;t=1&amp;cb=636574408348834173">"2017 Form 10-K"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=2017+Form+10-K&amp;rft_id=http%3A%2F%2Fphx.corporate-ir.net%2FExternal.File%3Fitem%3DUGFyZW50SUQ9NDAxNDU0fENoaWxkSUQ9LTF8VHlwZT0z%26t%3D1%26cb%3D636574408348834173&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-auto-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-auto_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-auto_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://fortune.com/fortune500/baxter-international/">"Baxter International"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">November 26,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=Baxter+International&amp;rft_id=http%3A%2F%2Ffortune.com%2Ffortune500%2Fbaxter-international%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text">"<a rel="nofollow" class="external text" href="http://www.baxter.com/about_baxter/contact_us/index.html">Contact Us</a>." Baxter International. Retrieved on February 2, 2011. "Corporate address: One Baxter Parkway Deerfield, IL 60015-4625."</span>
</li>
<li id="cite_note-2013_Form_10-K-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-2013_Form_10-K_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-2013_Form_10-K_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20140703204142/http://www.baxter.com/downloads/investors/reports_and_financials/annual_report/2013/2013_baxter_form10-K.pdf#page=51">"2013 Form 10-K"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.baxter.com/downloads/investors/reports_and_financials/annual_report/2013/2013_baxter_form10-K.pdf#page=51">the original</a> <span class="cs1-format">(PDF)</span> on July 3, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">July 14,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=2013+Form+10-K&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fdownloads%2Finvestors%2Freports_and_financials%2Fannual_report%2F2013%2F2013_baxter_form10-K.pdf%23page%3D51&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-history-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-history_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-history_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-history_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-history_5-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20090602055413/http://www.baxter.com/about_baxter/company_profile/sub/history.html">"History"</a>. Baxter International. Archived from <a rel="nofollow" class="external text" href="http://www.baxter.com/about_baxter/company_profile/sub/history.html">the original</a> on June 2, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">July 8,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=History&amp;rft.pub=Baxter+International&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fabout_baxter%2Fcompany_profile%2Fsub%2Fhistory.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-boycott-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-boycott_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-boycott_6-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Feiler, Gil (2005). <i>From Boycott to Economic Cooperation: The Political Economy of the Arab Boycott of Israel</i>. Frank Cass Publishers. p. 70.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=From+Boycott+to+Economic+Cooperation%3A+The+Political+Economy+of+the+Arab+Boycott+of+Israel&amp;rft.pages=70&amp;rft.pub=Frank+Cass+Publishers&amp;rft.date=2005&amp;rft.aulast=Feiler&amp;rft.aufirst=Gil&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-tribune90-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-tribune90_7-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Morris, Steven (March 17, 1990). <a rel="nofollow" class="external text" href="http://articles.chicagotribune.com/1990-03-17/business/9001220565_1_dr-richard-fuisz-baxter-spokesman-baxter-international">"Baxter Told To Pay Firm $15 Million"</a>. <i><a href="/wiki/Chicago_Tribune" title="Chicago Tribune">Chicago Tribune</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chicago+Tribune&amp;rft.atitle=Baxter+Told+To+Pay+Firm+%2415+Million&amp;rft.date=1990-03-17&amp;rft.aulast=Morris&amp;rft.aufirst=Steven&amp;rft_id=http%3A%2F%2Farticles.chicagotribune.com%2F1990-03-17%2Fbusiness%2F9001220565_1_dr-richard-fuisz-baxter-spokesman-baxter-international&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-edgar-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-edgar_8-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/2993/95013397001096/filing-main.htm">"FUISZ TECHNOLOGIES LTD, Form 10-K, Annual Report, Filing Date Mar 31, 1997"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">May 15,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FUISZ+TECHNOLOGIES+LTD%2C+Form+10-K%2C+Annual+Report%2C+Filing+Date+Mar+31%2C+1997&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F2993%2F95013397001096%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-mcall-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-mcall_9-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Kupper, Thom (January 29, 1992). <a rel="nofollow" class="external text" href="http://articles.mcall.com/1992-01-29/news/2844691_1_richard-fuisz-medcom-products-baxter">"<span class="cs1-kern-left">'</span>Whistle-blower' Left L.v. For Career"</a>. <i><a href="/wiki/The_Morning_Call" title="The Morning Call">The Morning Call</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Morning+Call&amp;rft.atitle=%27Whistle-blower%27+Left+L.v.+For+Career&amp;rft.date=1992-01-29&amp;rft.aulast=Kupper&amp;rft.aufirst=Thom&amp;rft_id=http%3A%2F%2Farticles.mcall.com%2F1992-01-29%2Fnews%2F2844691_1_richard-fuisz-medcom-products-baxter&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-bloomberg_1991-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-bloomberg_1991_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bloomberg_1991_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/bw/stories/1991-10-06/the-case-against-baxter-international">"The case against Baxter International"</a>. Bloomberg. October 6, 1991<span class="reference-accessdate">. Retrieved <span class="nowrap">October 17,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+case+against+Baxter+International&amp;rft.pub=Bloomberg&amp;rft.date=1991-10-06&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fbw%2Fstories%2F1991-10-06%2Fthe-case-against-baxter-international&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-washreport-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-washreport_11-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Curtiss, Richard (July–August 1994). <a rel="nofollow" class="external text" href="https://www.wrmea.org/wrmea-archives/156-washington-report-archives-1994-1999/july-august-1994/7546-pollard-mentor-rafael-eitan-turns-up-in-castros-cuba.html">"People Watch"</a>. <i><a href="/wiki/Washington_Report_on_Middle_East_Affairs" title="Washington Report on Middle East Affairs">Washington Report on Middle East Affairs</a></i>. p. 45.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Washington+Report+on+Middle+East+Affairs&amp;rft.atitle=People+Watch&amp;rft.pages=45&amp;rft.date=1994-07%2F1994-08&amp;rft.aulast=Curtiss&amp;rft.aufirst=Richard&amp;rft_id=http%3A%2F%2Fwww.wrmea.org%2Fwrmea-archives%2F156-washington-report-archives-1994-1999%2Fjuly-august-1994%2F7546-pollard-mentor-rafael-eitan-turns-up-in-castros-cuba.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-tribune93-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-tribune93_12-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Morris, Steven (March 26, 1993). <a rel="nofollow" class="external text" href="http://articles.chicagotribune.com/1993-03-26/business/9303260280_1_dr-richard-fuisz-anti-boycott-baxter-international">"$6 Million From Baxter"</a>. <i><a href="/wiki/Chicago_Tribune" title="Chicago Tribune">Chicago Tribune</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chicago+Tribune&amp;rft.atitle=%246+Million+From+Baxter&amp;rft.date=1993-03-26&amp;rft.aulast=Morris&amp;rft.aufirst=Steven&amp;rft_id=http%3A%2F%2Farticles.chicagotribune.com%2F1993-03-26%2Fbusiness%2F9303260280_1_dr-richard-fuisz-anti-boycott-baxter-international&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Mintzberg-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mintzberg_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mintzberg_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Mintzberg_13-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Mintzberg, Henry (2004). <span class="cs1-lock-registration" title="Free registration required"><a rel="nofollow" class="external text" href="https://archive.org/details/managersnotmbash00mint"><i>Managers Not MBAs: A Hard Look at the Soft Practice of Managing and Management Development</i></a></span>. San Francisco, Calif: Berrett-Koehler Publishers. p. <a rel="nofollow" class="external text" href="https://archive.org/details/managersnotmbash00mint/page/115">115</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/1-57675-275-5" title="Special:BookSources/1-57675-275-5"><bdi>1-57675-275-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Managers+Not+MBAs%3A+A+Hard+Look+at+the+Soft+Practice+of+Managing+and+Management+Development&amp;rft.place=San+Francisco%2C+Calif&amp;rft.pages=115&amp;rft.pub=Berrett-Koehler+Publishers&amp;rft.date=2004&amp;rft.isbn=1-57675-275-5&amp;rft.au=Mintzberg%2C+Henry&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fmanagersnotmbash00mint&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-nytimes_1985-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-nytimes_1985_14-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Crudele, John (July 16, 1985). <a rel="nofollow" class="external text" href="https://www.nytimes.com/1985/07/16/business/baxter-s-merger-bid-accepted.html">"Baxter's Merger Bid Accepted Published: July 16, 1985"</a>. <i>New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 17,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=Baxter%27s+Merger+Bid+Accepted+Published%3A+July+16%2C+1985&amp;rft.date=1985-07-16&amp;rft.au=Crudele%2C+John&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1985%2F07%2F16%2Fbusiness%2Fbaxter-s-merger-bid-accepted.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-modernhealthcare_2006-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-modernhealthcare_2006_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-modernhealthcare_2006_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Finkel, Ed (March 27, 2006). <a rel="nofollow" class="external text" href="http://www.modernhealthcare.com/article/20060327/NEWS/60823001">"Profile of Vernon Loucks  Spinning off success: Loucks helped mentor a cadre of future leaders at Baxter"</a>. <i>Modern Healthcare</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 17,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Modern+Healthcare&amp;rft.atitle=Profile+of+Vernon+Loucks++Spinning+off+success%3A+Loucks+helped+mentor+a+cadre+of+future+leaders+at+Baxter&amp;rft.date=2006-03-27&amp;rft.au=Finkel%2C+Ed&amp;rft_id=http%3A%2F%2Fwww.modernhealthcare.com%2Farticle%2F20060327%2FNEWS%2F60823001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-chicagotribune_1995-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-chicagotribune_1995_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-chicagotribune_1995_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-chicagotribune_1995_16-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Yates, Ronald E. (June 19, 1995). <a rel="nofollow" class="external text" href="http://articles.chicagotribune.com/1995-06-19/business/9506190063_1_baxter-international-million-settlement-bear-stearns">"Caremark Wounds Not Deep Penalty Could Have Been More Damaging"</a>. <i>Chicago Tribune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 17,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chicago+Tribune&amp;rft.atitle=Caremark+Wounds+Not+Deep+Penalty+Could+Have+Been+More+Damaging&amp;rft.date=1995-06-19&amp;rft.au=Yates%2C+Ronald+E.&amp;rft_id=http%3A%2F%2Farticles.chicagotribune.com%2F1995-06-19%2Fbusiness%2F9506190063_1_baxter-international-million-settlement-bear-stearns&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Feldman_1999-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-Feldman_1999_17-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Feldman, EA; Bayer R (1999). <i>Blood feuds: AIDS, blood, and the politics of medical disaster</i>. <a href="/wiki/Oxford_University_Press" title="Oxford University Press">Oxford University Press</a>. pp. <a rel="nofollow" class="external text" href="https://books.google.com/books?id=mcRp6cvcTm4C&amp;pg=PA49">49–50</a>, <a rel="nofollow" class="external text" href="https://books.google.com/books?id=mcRp6cvcTm4C&amp;pg=PA320">320</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/0-19-513160-6" title="Special:BookSources/0-19-513160-6"><bdi>0-19-513160-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Blood+feuds%3A+AIDS%2C+blood%2C+and+the+politics+of+medical+disaster&amp;rft.pages=49-50%2C+320&amp;rft.pub=Oxford+University+Press&amp;rft.date=1999&amp;rft.isbn=0-19-513160-6&amp;rft.aulast=Feldman&amp;rft.aufirst=EA&amp;rft.au=Bayer+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://archive.today/20120707122636/http://articles.boston.com/2011-11-10/business/30382914_1_baxter-international-baxa-syringes">"Baxter Int'l finishes $380M Baxa Corp purchase"</a>. <i>The Boston Globe</i>. Archived from <a rel="nofollow" class="external text" href="http://articles.boston.com/2011-11-10/business/30382914_1_baxter-international-baxa-syringes">the original</a> on July 7, 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Boston+Globe&amp;rft.atitle=Baxter+Int%27l+finishes+%24380M+Baxa+Corp+purchase&amp;rft_id=http%3A%2F%2Farticles.boston.com%2F2011-11-10%2Fbusiness%2F30382914_1_baxter-international-baxa-syringes&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-History-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-History_19-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/finance/stocks/HIK.L/key-developments/article/2304890">"Hikma Pharmaceuticals Plc Completes Acquisition of Baxter Healthcare Corporation's Multi-Source Injectables Business"</a>. <i>Reuters. Retrieved May 3, 2011</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters.+Retrieved+May+3%2C+2011&amp;rft.atitle=Hikma+Pharmaceuticals+Plc+Completes+Acquisition+of+Baxter+Healthcare+Corporation%27s+Multi-Source+Injectables+Business&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FHIK.L%2Fkey-developments%2Farticle%2F2304890&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130626185157/http://www.hikma.com/en/about-hikma/our-history.aspx">"History"</a>. <i>Hikma Pharmaceuticals PLC</i>. Archived from <a rel="nofollow" class="external text" href="http://www.hikma.com/en/about-hikma/our-history.aspx">the original</a> on June 26, 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">May 11,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Hikma+Pharmaceuticals+PLC&amp;rft.atitle=History&amp;rft_id=http%3A%2F%2Fwww.hikma.com%2Fen%2Fabout-hikma%2Four-history.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite class="citation news">Foo Yun Chee (July 10, 2013). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/2013/07/10/us-baxterinternational-gambro-eu-idUSBRE9690ML20130710">"EU to clear Baxter's $4 billion buy of Sweden's Gambro: sources"</a>. <i>Reuters</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=EU+to+clear+Baxter%27s+%244+billion+buy+of+Sweden%27s+Gambro%3A+sources&amp;rft.date=2013-07-10&amp;rft.au=Foo+Yun+Chee&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2013%2F07%2F10%2Fus-baxterinternational-gambro-eu-idUSBRE9690ML20130710&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://sandp500changes.whw1.com/#D20150701-BXLT-QEP">"Baxalta Added and QEP Resources Deleted"</a>. SandP500changes.whw1.com. July 1, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">July 1,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Baxalta+Added+and+QEP+Resources+Deleted&amp;rft.pub=SandP500changes.whw1.com&amp;rft.date=2015-07-01&amp;rft_id=http%3A%2F%2Fsandp500changes.whw1.com%2F%23D20150701-BXLT-QEP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20141128175339/http://www.baxter.com/press_room/press_releases/2014/07_30_14_vaccines.html">"Archived copy"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.baxter.com/press_room/press_releases/2014/07_30_14_vaccines.html">the original</a> on November 28, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">November 18,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fpress_room%2Fpress_releases%2F2014%2F07_30_14_vaccines.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><cite class="citation web">Russell, John. <a rel="nofollow" class="external text" href="http://www.chicagotribune.com/business/ct-baxter-names-new-ceo-1029-biz-20151028-story.html">"Baxter names new CEO"</a>. <i>The Chicago Tribune</i>. The Chicago Tribune.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Chicago+Tribune&amp;rft.atitle=Baxter+names+new+CEO&amp;rft.aulast=Russell&amp;rft.aufirst=John&amp;rft_id=http%3A%2F%2Fwww.chicagotribune.com%2Fbusiness%2Fct-baxter-names-new-ceo-1029-biz-20151028-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><cite class="citation news">Ward, Andrew. <a rel="nofollow" class="external text" href="https://www.ft.com/content/bb4b97d4-b2cf-11e5-b147-e5e5bba42e51">"Shire agrees $32bn takeover of Baxalta"</a>. FT.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Shire+agrees+%2432bn+takeover+of+Baxalta&amp;rft.aulast=Ward&amp;rft.aufirst=Andrew&amp;rft_id=https%3A%2F%2Fwww.ft.com%2Fcontent%2Fbb4b97d4-b2cf-11e5-b147-e5e5bba42e51&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/baxter-buys-claris-generic-injectables-subsidiary-for-625m/81253563">"Baxter Buys Claris' Generic Injectables Subsidiary for $625M - GEN Genetic Engineering &amp; Biotechnology News - Biotech from Bench to Business - GEN"</a>. <i>GEN</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 16,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Baxter+Buys+Claris%27+Generic+Injectables+Subsidiary+for+%24625M+-+GEN+Genetic+Engineering+%26+Biotechnology+News+-+Biotech+from+Bench+to+Business+-+GEN&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fbaxter-buys-claris-generic-injectables-subsidiary-for-625m%2F81253563&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.biospace.com/article/releases/baxter-to-expand-advanced-surgery-portfolio-with-acquisition-of-seprafilm-adhesion-barrier/?s=79">https://www.biospace.com/article/releases/baxter-to-expand-advanced-surgery-portfolio-with-acquisition-of-seprafilm-adhesion-barrier/?s=79</a></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.businesswire.com/news/home/20191202005209/en/">https://www.businesswire.com/news/home/20191202005209/en/</a></span>
</li>
<li id="cite_note-Klinkers1999-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-Klinkers1999_29-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Bennett M; James P (1999). "The Evolution of Integrated Environmental Performance Evaluation and Reporting".  In Klinkers L; Bennett M; James P (eds.). <i>Sustainable Measures: Evaluation and Reporting of Environmental and Social Performance</i>. Greenleaf Pubns. pp. <a rel="nofollow" class="external text" href="https://books.google.com/books?id=I0iChJeHaC4C&amp;pg=PA253">253–282</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/1-874719-16-0" title="Special:BookSources/1-874719-16-0"><bdi>1-874719-16-0</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=The+Evolution+of+Integrated+Environmental+Performance+Evaluation+and+Reporting&amp;rft.btitle=Sustainable+Measures%3A+Evaluation+and+Reporting+of+Environmental+and+Social+Performance&amp;rft.pages=253-282&amp;rft.pub=Greenleaf+Pubns&amp;rft.date=1999&amp;rft.isbn=1-874719-16-0&amp;rft.au=Bennett+M%3B+James+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-greengreedy-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-greengreedy_30-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Adelson, G; Engell J; Ranalli B; Van Anglen KP. <i>Environment: An Interdisciplinary Anthology</i>. <a href="/wiki/Yale_University_Press" title="Yale University Press">Yale University Press</a>. pp. <a rel="nofollow" class="external text" href="https://books.google.com/books?id=_Cy9xMIoCdUC&amp;pg=PA254">254–5</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/0-300-11077-4" title="Special:BookSources/0-300-11077-4"><bdi>0-300-11077-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Environment%3A+An+Interdisciplinary+Anthology&amp;rft.pages=254-5&amp;rft.pub=Yale+University+Press&amp;rft.isbn=0-300-11077-4&amp;rft.aulast=Adelson&amp;rft.aufirst=G&amp;rft.au=Engell+J&amp;rft.au=Ranalli+B&amp;rft.au=Van+Anglen+KP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-emissions-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-emissions_31-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20090621075303/http://www.environmentalleader.com/2009/06/19/baxter-cuts-ghg-emissions-by-21/">"Baxter Cuts GHG Emissions by 21%"</a>. Environmentalleader.com. June 19, 2009. Archived from <a rel="nofollow" class="external text" href="http://www.environmentalleader.com/2009/06/19/baxter-cuts-ghg-emissions-by-21/">the original</a> on June 21, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">July 3,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Baxter+Cuts+GHG+Emissions+by+21%25&amp;rft.pub=Environmentalleader.com&amp;rft.date=2009-06-19&amp;rft_id=http%3A%2F%2Fwww.environmentalleader.com%2F2009%2F06%2F19%2Fbaxter-cuts-ghg-emissions-by-21%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-corpoverview-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-corpoverview_32-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.baxter.com/about_baxter/company_profile/corporate_overview.html">"Corporate Overview"</a>. Baxter International. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20101120024936/http://baxter.com/about_baxter/company_profile/corporate_overview.html">Archived</a> from the original on November 20, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">November 5,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Corporate+Overview&amp;rft.pub=Baxter+International&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fabout_baxter%2Fcompany_profile%2Fcorporate_overview.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Davis2003-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-Davis2003_33-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Davis, JA (2003). "Purifying an image: Baxter International and the Dialyzer Crisis".  In Feigenbaum AV (ed.). <i>The power of management capital: utilizing the new drivers of innovation, profitability, and growth in a demanding global economy</i>. <a href="/wiki/McGraw-Hill" class="mw-redirect" title="McGraw-Hill">McGraw-Hill</a> Professional. pp. <a rel="nofollow" class="external text" href="https://books.google.com/books?id=eeXbNc5BjwQC&amp;pg=PA349">349–364</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/0-07-021733-5" title="Special:BookSources/0-07-021733-5"><bdi>0-07-021733-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Purifying+an+image%3A+Baxter+International+and+the+Dialyzer+Crisis&amp;rft.btitle=The+power+of+management+capital%3A+utilizing+the+new+drivers+of+innovation%2C+profitability%2C+and+growth+in+a+demanding+global+economy&amp;rft.pages=349-364&amp;rft.pub=McGraw-Hill+Professional&amp;rft.date=2003&amp;rft.isbn=0-07-021733-5&amp;rft.aulast=Davis&amp;rft.aufirst=JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.baxter.com/about_baxter/company_profile/corporate_overview.html">"Corporate overview"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Corporate+overview&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fabout_baxter%2Fcompany_profile%2Fcorporate_overview.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzcwODQxfENoaWxkSUQ9LTF8VHlwZT0z&amp;t=1&amp;cb=636253845617338842">"Baxter Form 10-K for year ended 2016"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Baxter+Form+10-K+for+year+ended+2016&amp;rft_id=http%3A%2F%2Fphx.corporate-ir.net%2FExternal.File%3Fitem%3DUGFyZW50SUQ9MzcwODQxfENoaWxkSUQ9LTF8VHlwZT0z%26t%3D1%26cb%3D636253845617338842&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-wsj_1999-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-wsj_1999_36-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Schellhardt, Timothy D. (April 29, 1999). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB925337647950346340">"To a Pile of CEO Perks, Add the 'Special' Bonus"</a>. <i>The Wall Street Journal</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 18,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=To+a+Pile+of+CEO+Perks%2C+Add+the+%27Special%27+Bonus&amp;rft.date=1999-04-29&amp;rft.au=Schellhardt%2C+Timothy+D.&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB925337647950346340&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.upi.com/Health_News/2009/06/13/Baxter-to-release-flu-vaccine-in-July/UPI-41571244908860/">"Baxter to release flu vaccine in July"</a>. United Press International. June 13, 2009. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20090616050354/http://www.upi.com/Health_News/2009/06/13/Baxter-to-release-flu-vaccine-in-July/UPI-41571244908860/">Archived</a> from the original on June 16, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">July 2,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Baxter+to+release+flu+vaccine+in+July&amp;rft.date=2009-06-13&amp;rft_id=http%3A%2F%2Fwww.upi.com%2FHealth_News%2F2009%2F06%2F13%2FBaxter-to-release-flu-vaccine-in-July%2FUPI-41571244908860%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Baxter_2014_ed-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-Baxter_2014_ed_38-0">^</a></b></span> <span class="reference-text"><cite class="citation"><a rel="nofollow" class="external text" href="http://www.baxter.com/assets/downloads/baxter-sustainability-report-2014.pdf">"Education and Critical Community Needs"</a> <span class="cs1-format">(PDF)</span>, <i>Baxter</i>, Baxter sustainability report, 2015<span class="reference-accessdate">, retrieved <span class="nowrap">October 18,</span> 2015</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Baxter&amp;rft.atitle=Education+and+Critical+Community+Needs&amp;rft.date=2015&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fassets%2Fdownloads%2Fbaxter-sustainability-report-2014.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20140706034058/http://www.civic50.org/2013_results.php">"The Civic 50 website, 2013 results"</a>. <i>Civic50.org</i>. Archived from <a rel="nofollow" class="external text" href="http://www.civic50.org/2013_results.php">the original</a> on July 6, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">July 16,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Civic50.org&amp;rft.atitle=The+Civic+50+website%2C+2013+results&amp;rft_id=http%3A%2F%2Fwww.civic50.org%2F2013_results.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Baxter_2014_em-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-Baxter_2014_em_40-0">^</a></b></span> <span class="reference-text"><cite class="citation"><a rel="nofollow" class="external text" href="http://www.baxter.com/assets/downloads/baxter-sustainability-report-2014.pdf">"Employee Involvement"</a> <span class="cs1-format">(PDF)</span>, <i>Baxter</i>, Baxter sustainability report, 2015<span class="reference-accessdate">, retrieved <span class="nowrap">October 18,</span> 2015</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Baxter&amp;rft.atitle=Employee+Involvement&amp;rft.date=2015&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fassets%2Fdownloads%2Fbaxter-sustainability-report-2014.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Baxter_2014_cm-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-Baxter_2014_cm_41-0">^</a></b></span> <span class="reference-text"><cite class="citation"><a rel="nofollow" class="external text" href="http://www.baxter.com/assets/downloads/baxter-sustainability-report-2014.pdf">"Community Support"</a> <span class="cs1-format">(PDF)</span>, <i>Baxter</i>, Baxter sustainability report, 2015<span class="reference-accessdate">, retrieved <span class="nowrap">October 18,</span> 2015</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Baxter&amp;rft.atitle=Community+Support&amp;rft.date=2015&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fassets%2Fdownloads%2Fbaxter-sustainability-report-2014.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20150603072124/http://www.baxter.com/press_room/press_releases/2014/06_25_14_sustainability.html">"Press Room: Press Releases – Baxter"</a>. <i>www.Baxter.com</i>. June 2014. Archived from <a rel="nofollow" class="external text" href="http://www.baxter.com/press_room/press_releases/2014/06_25_14_sustainability.html">the original</a> on June 3, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">July 16,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.Baxter.com&amp;rft.atitle=Press+Room%3A+Press+Releases+%E2%80%93+Baxter&amp;rft.date=2014-06&amp;rft_id=http%3A%2F%2Fwww.baxter.com%2Fpress_room%2Fpress_releases%2F2014%2F06_25_14_sustainability.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://health.gov.ie/wp-content/uploads/2014/04/Tribunal-of-Inquiry-into-the-Infection-with-HIV-and-Hep-C-of-persons-with-Haemophilia-and-Related-Matters.pdf">"Report of the Tribunal of Inquiry into the Infection with HIV and Hepatitis C of Persons with Haemophilia and Related Matters"</a> <span class="cs1-format">(PDF)</span>. <i>health.gov.ie</i>. 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">June 2,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=health.gov.ie&amp;rft.atitle=Report+of+the+Tribunal+of+Inquiry+into+the+Infection+with+HIV+and+Hepatitis+C+of+Persons+with+Haemophilia+and+Related+Matters&amp;rft.date=2014&amp;rft_id=https%3A%2F%2Fhealth.gov.ie%2Fwp-content%2Fuploads%2F2014%2F04%2FTribunal-of-Inquiry-into-the-Infection-with-HIV-and-Hep-C-of-persons-with-Haemophilia-and-Related-Matters.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text">Class Action Complaint (2004) Case No. C032572 PJH. Page 24.</span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><cite class="citation web">Letter, The Pharma. <a rel="nofollow" class="external text" href="http://www.thepharmaletter.com/article/baxter-agrees-to-settle-japan-hiv-lawsuit">"Baxter Agrees To Settle Japan HIV Lawsuit"</a>. <i>www.ThePharmaLetter.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.ThePharmaLetter.com&amp;rft.atitle=Baxter+Agrees+To+Settle+Japan+HIV+Lawsuit&amp;rft.aulast=Letter&amp;rft.aufirst=The+Pharma&amp;rft_id=http%3A%2F%2Fwww.thepharmaletter.com%2Farticle%2Fbaxter-agrees-to-settle-japan-hiv-lawsuit&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20131012151427/http://biomed.brown.edu/Courses/BI108/BI108_2007_Groups/group05/pages/baxter.html">"Baxter Dialyzer Recall"</a>. <i>Major Recalls of Organ Replacement Devices</i>. Archived from <a rel="nofollow" class="external text" href="http://biomed.brown.edu/Courses/BI108/BI108_2007_Groups/group05/pages/baxter.html">the original</a> on October 12, 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">October 12,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Major+Recalls+of+Organ+Replacement+Devices&amp;rft.atitle=Baxter+Dialyzer+Recall&amp;rft_id=http%3A%2F%2Fbiomed.brown.edu%2FCourses%2FBI108%2FBI108_2007_Groups%2Fgroup05%2Fpages%2Fbaxter.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2001/11/14/business/baxter-faces-suit-on-dialysis-deaths.html">"Baxter Faces Suit On Dialysis Deaths"</a>. <i>New York Times</i>. November 14, 2001<span class="reference-accessdate">. Retrieved <span class="nowrap">October 12,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=Baxter+Faces+Suit+On+Dialysis+Deaths&amp;rft.date=2001-11-14&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2001%2F11%2F14%2Fbusiness%2Fbaxter-faces-suit-on-dialysis-deaths.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-John_Wiley_&amp;_Sons-48"><span class="mw-cite-backlink">^ <a href="#cite_ref-John_Wiley_&amp;_Sons_48-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-John_Wiley_&amp;_Sons_48-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Hubbard, Douglas (May 15, 2009). <i>The Failure of Risk Management: Why It's Broken and How to Fix It</i>. John Wiley &amp; Sons. p. 15. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0470387955" title="Special:BookSources/978-0470387955"><bdi>978-0470387955</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Failure+of+Risk+Management%3A+Why+It%27s+Broken+and+How+to+Fix+It&amp;rft.pages=15&amp;rft.pub=John+Wiley+%26+Sons&amp;rft.date=2009-05-15&amp;rft.isbn=978-0470387955&amp;rft.aulast=Hubbard&amp;rft.aufirst=Douglas&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-wp1-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-wp1_49-0">^</a></b></span> <span class="reference-text">"Contaminant Found in Blood Thinner", <i>Washington Post</i> (Online edition), March 5, 2008</span>
</li>
<li id="cite_note-reuters1-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-reuters1_50-0">^</a></b></span> <span class="reference-text">"Baxter probe focuses on US-owned China plant – WSJ", Reuters, February 15, 2008</span>
</li>
<li id="cite_note-wsj1-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-wsj1_51-0">^</a></b></span> <span class="reference-text">"China Washes Hands on Heparin Purity", <i>Wall Street Journal</i> (Online edition) February 27, 2008</span>
</li>
<li id="cite_note-time1-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-time1_52-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.time.com/time/magazine/article/0,9171,1858870,00.html">"Heparin's Deadly Side Effects"</a>. <i>Time magazine</i>. November 13, 2008. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20081121194220/http://www.time.com/time/magazine/article/0%2C9171%2C1858870%2C00.html">Archived</a> from the original on November 21, 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">November 16,</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Time+magazine&amp;rft.atitle=Heparin%27s+Deadly+Side+Effects&amp;rft.date=2008-11-13&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fmagazine%2Farticle%2F0%2C9171%2C1858870%2C00.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><cite class="citation web">Zawisza, Julie (March 29, 2008). <a rel="nofollow" class="external text" href="https://www.fda.gov/downloads/NewsEvents/Newsroom/MediaTranscripts/UCM169335.pdf">"FDA Media Briefing on Heparin"</a> <span class="cs1-format">(PDF)</span>. <a href="/wiki/U.S._Food_and_Drug_Administration" class="mw-redirect" title="U.S. Food and Drug Administration">U.S. Food and Drug Administration</a><span class="reference-accessdate">. Retrieved <span class="nowrap">April 23,</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Media+Briefing+on+Heparin&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft.date=2008-03-29&amp;rft.aulast=Zawisza&amp;rft.aufirst=Julie&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdownloads%2FNewsEvents%2FNewsroom%2FMediaTranscripts%2FUCM169335.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><cite class="citation news"><a href="/wiki/Walt_Bogdanich" title="Walt Bogdanich">Bogdanich, Walt</a> (March 20, 2008). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/03/20/health/20heparin.html?hp=&amp;adxnnl=1&amp;adxnnlx=1206032448-8vAmKaxtXzpFTH3rUaNgBg">"Heparin Find May Point to Chinese Counterfeiting"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">March 20,</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Heparin+Find+May+Point+to+Chinese+Counterfeiting&amp;rft.date=2008-03-20&amp;rft.aulast=Bogdanich&amp;rft.aufirst=Walt&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2008%2F03%2F20%2Fhealth%2F20heparin.html%3Fhp%3D%26adxnnl%3D1%26adxnnlx%3D1206032448-8vAmKaxtXzpFTH3rUaNgBg&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/apps/news?pid=newsarchive&amp;sid=aTo3LbhcA75I">"Baxter Sent Bird Flu Virus to European Labs by Error"</a>. <i><a href="/wiki/Bloomberg_L.P." title="Bloomberg L.P.">Bloomberg L.P.</a></i> February 24, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">August 8,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+L.P.&amp;rft.atitle=Baxter+Sent+Bird+Flu+Virus+to+European+Labs+by+Error&amp;rft.date=2009-02-24&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fapps%2Fnews%3Fpid%3Dnewsarchive%26sid%3DaTo3LbhcA75I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-CTV_2009-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-CTV_2009_56-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20090302043044/http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20090227/Bird_Flu_090227/20090227?hub=Health">"Baxter admits flu product contained live bird flu virus"</a>. <i>CTV</i>. <a href="/wiki/The_Canadian_Press" title="The Canadian Press">The Canadian Press</a>. February 27, 2009. Archived from <a rel="nofollow" class="external text" href="http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20090227/Bird_Flu_090227/20090227?hub=Health">the original</a> on March 2, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CTV&amp;rft.atitle=Baxter+admits+flu+product+contained+live+bird+flu+virus&amp;rft.date=2009-02-27&amp;rft_id=http%3A%2F%2Fwww.ctv.ca%2Fservlet%2FArticleNews%2Fstory%2FCTVNews%2F20090227%2FBird_Flu_090227%2F20090227%3Fhub%3DHealth&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><cite class="citation news">Jack, A (March 16, 2009). <a rel="nofollow" class="external text" href="https://www.ft.com/cms/s/0/d7a3e3d6-1237-11de-b816-0000779fd2ac.html?nclick_check=1">"WHO mulls stricter transport of bio products"</a>. <i>Financial Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 16,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Financial+Times&amp;rft.atitle=WHO+mulls+stricter+transport+of+bio+products&amp;rft.date=2009-03-16&amp;rft.aulast=Jack&amp;rft.aufirst=A&amp;rft_id=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fd7a3e3d6-1237-11de-b816-0000779fd2ac.html%3Fnclick_check%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><cite class="citation news">Tracy, B (July 3, 2009). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20090709064537/http://www.kypost.com/content/news/commonwealth/story/Conway-Announces-Multi-Million-Dollar-Settlement/srxPJ5GaiU2gqFfhozY9-g.cspx">"Conway Announces Multi-Million Dollar Settlement With Drug Company"</a>. <i><a href="/wiki/The_Cincinnati_Post" title="The Cincinnati Post">Kentucky Post</a></i>. <a href="/wiki/E._W._Scripps_Company" title="E. W. Scripps Company">E. W. Scripps Company</a>. Archived from <a rel="nofollow" class="external text" href="http://www.kypost.com/content/news/commonwealth/story/Conway-Announces-Multi-Million-Dollar-Settlement/srxPJ5GaiU2gqFfhozY9-g.cspx">the original</a> on July 9, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">July 3,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kentucky+Post&amp;rft.atitle=Conway+Announces+Multi-Million+Dollar+Settlement+With+Drug+Company&amp;rft.date=2009-07-03&amp;rft.aulast=Tracy&amp;rft.aufirst=B&amp;rft_id=http%3A%2F%2Fwww.kypost.com%2Fcontent%2Fnews%2Fcommonwealth%2Fstory%2FConway-Announces-Multi-Million-Dollar-Settlement%2FsrxPJ5GaiU2gqFfhozY9-g.cspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.businessweek.com/news/2010-05-08/teva-baxter-will-fight-500-million-in-damages-over-propofol.html">"Teva, Baxter Will Fight $500 Million in Damages Over Propofol", <i>Business Week</i>, May 8, 2010</a></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://investor.baxter.com/phoenix.zhtml?c=86121&amp;p=irol-reportsannual;">"2011 annual report, page 87"</a>. <i>Baxter.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 16,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Baxter.com&amp;rft.atitle=2011+annual+report%2C+page+87&amp;rft_id=http%3A%2F%2Finvestor.baxter.com%2Fphoenix.zhtml%3Fc%3D86121%26p%3Dirol-reportsannual%3B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm210664.htm">"FDA Issues Statement on Baxter's Recall of Colleague Infusion Pumps"</a>. FDA. FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">May 3,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=FDA+Issues+Statement+on+Baxter%27s+Recall+of+Colleague+Infusion+Pumps&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm210664.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><cite class="citation news">Portero, Ashley. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120107173713/http://www.ibtimes.com/articles/264481/20111209/30-major-u-s-corporations-paid-lobby.htm">"30 Major U.S. Corporations Paid More to Lobby Congress Than Income Taxes, 2008–2010"</a>. <i><a href="/wiki/International_Business_Times" title="International Business Times">International Business Times</a></i>. Archived from <a rel="nofollow" class="external text" href="http://www.ibtimes.com/articles/264481/20111209/30-major-u-s-corporations-paid-lobby.htm">the original</a> on January 7, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">December 26,</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Business+Times&amp;rft.atitle=30+Major+U.S.+Corporations+Paid+More+to+Lobby+Congress+Than+Income+Taxes%2C+2008%E2%80%932010&amp;rft.aulast=Portero&amp;rft.aufirst=Ashley&amp;rft_id=http%3A%2F%2Fwww.ibtimes.com%2Farticles%2F264481%2F20111209%2F30-major-u-s-corporations-paid-lobby.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaxter+International" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(9)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Baxter_International&amp;action=edit&amp;section=20" title="Edit section: External links" data-section="20" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-9 collapsible-block" id="mf-section-9">

<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000"><tbody><tr>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Baxter_International" class="extiw" title="commons:Category:Baxter International"><span style="">Baxter International</span></a></b></i>.</td></tr></tbody></table><ul><li><span class="official-website"><span class="url"><a rel="nofollow" class="external text" href="http://www.Baxter.com/">Official website</a></span></span></li>
<li>Business data for Baxter International: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=BAX">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=BAX">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=BAX">SEC filings</a></li></ul></div></li></ul>





</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Baxter_International&amp;oldid=945745743">https://en.wikipedia.org/w/index.php?title=Baxter_International&amp;oldid=945745743</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Baxter_International"
				data-user-name="IznoRepeat"
				data-user-gender="unknown"
				data-timestamp="1584309221">
				<span>Last edited on 15 March 2020, at 21:53</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Baxter_International&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.804","walltime":"0.997","ppvisitednodes":{"value":3924,"limit":1000000},"postexpandincludesize":{"value":149725,"limit":2097152},"templateargumentsize":{"value":3732,"limit":2097152},"expansiondepth":{"value":14,"limit":40},"expensivefunctioncount":{"value":4,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":177725,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00%  848.286      1 -total"," 48.24%  409.233      1 Template:Reflist"," 22.78%  193.257      1 Template:Infobox_company"," 21.09%  178.912      1 Template:Infobox"," 20.67%  175.341     23 Template:Cite_web"," 13.75%  116.600     21 Template:Cite_news","  8.51%   72.197      9 Template:Wikidata","  7.69%   65.255      1 Template:Br_separated_entries","  5.53%   46.893      1 Template:Use_mdy_dates","  5.23%   44.384      1 Template:Commons_category"]},"scribunto":{"limitreport-timeusage":{"value":"0.419","limit":"10.000"},"limitreport-memusage":{"value":6979430,"limit":52428800}},"cachereport":{"origin":"mw1272","timestamp":"20200417051633","ttl":86400,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Baxter International","url":"https:\/\/en.wikipedia.org\/wiki\/Baxter_International","sameAs":"http:\/\/www.wikidata.org\/entity\/Q761965","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q761965","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2005-08-11T20:51:33Z","dateModified":"2020-03-15T21:53:41Z","headline":"American manufacturer of healthcare goods"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":121,"wgHostname":"mw1264"});});</script>		</body>
		</html>
		